HAL vs IMNM · P/E 9.3, $19.05B cap vs rev $9.0M
Halliburton Company (HAL) versus Immunome Inc (IMNM) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Immunome Inc (IMNM) is a biotechnology company listed on US.
HAL does not have a complete income-statement cache yet.
Latest reported IMNM revenue for 2024-12-31 was $9.0M. Net income was -$293.0M. Revenue was down 35.5% from 2023-12-31 to 2024-12-31. IMNM currently screens at market cap $2.47B.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. IMNM currently screens at market cap $2.47B.
Not investment advice. Open the HAL and IMNM stock pages for the full models.
Not investment advice.